Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Agios Pharmaceuticals, Inc.
About AGIO
Agios Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is focused on developing and delivering transformative therapies for patients living with rare diseases. It markets a first-in-class pyruvate kinase (PK) activator for adults with PK deficiency, the first disease-modifying therapy for debilitating hemolytic anemia. Its lead product candidate in its portfolio, PYRUKYND (mitapivat), is an activator of both wild-type and mutant pyruvate kinase, or PK, enzymes for the potential treatment of hemolytic anemias. It is also developing tebapivat, a novel PK activator, for the potential treatment of lower-risk myelodysplastic syndromes, or LR MDS, and hemolytic anemias; AG-181, its phenylalanine hydroxylase, or PAH, stabilizer for the potential treatment of phenylketonuria, or PKU; and AG-236, an siRNA in-licensed from Alnylam Pharmaceuticals, Inc., targeting the transmembrane serine protease 6, or TMPRSS6 gene for the potential treatment of polycythemia vera, or PV.
Market Capitalisation
$1.69B
Price-earnings ratio
-
Dividend yield
0.00%
Volume
293.52K
High today
$28.73
Low today
$28.08
Open price
$28.21
52-week high
$46.00
52-week low
$22.24
Ready to start your investing journey with Stake?
Open an accountHow do I buy AGIO shares in Australia?
Buying AGIO shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Agios Pharmaceuticals, Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in AGIO
What is the ticker symbol of Agios Pharmaceuticals, Inc.?
The ticker symbol for Agios Pharmaceuticals, Inc. is AGIO.
How much is one share of AGIO?
One share of AGIO is valued at $28.70 as of 13 May 2026.
What is the market capitalisation of Agios Pharmaceuticals, Inc. AGIO?
As of 13 May 2026 Agios Pharmaceuticals, Inc. has a market cap of $1.69B.
What is the 52-week high for Agios Pharmaceuticals, Inc. stock?
The Agios Pharmaceuticals, Inc. 52-week high stock price is $46.00.
What is the 52-week low for Agios Pharmaceuticals, Inc. stock?
The Agios Pharmaceuticals, Inc. 52-week low stock price is $22.24.
Can I buy AGIO shares through Stake, an investing platform like Sharesies and Hatch Invest?
Yes, the Stake investing platform allows you to buy AGIO shares and over 9,500 more stocks and ETFs on Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in AGIO on Stake
- Buy AGIO from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of AGIO from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
AGIO related stocks